Pharmacology

Topics

Acute Heart Failure (28)
Advanced Heart Failure (42)
Basic Science (12)
Biomarkers (24)
Clinical Trial Methodology and Predictive Models (8)
CME-MOC (12)
Comorbidities (19)
CT Coronary Angiography
Heart Failure with Preserved Ejection Fraction (HFpEF) (32)
Heart Failure-Electrophysiology (10)
Heart Failure-Imaging (4)
Non-pharmacologic Therapies (8)
Outcomes and Quality (23)
Pharmacology (27)
Right Heart Failure and Pulmonary Hypertension (3)
Special Populations and Global Health (11)

Latest Articles

Restricted access
Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart FailureThe Devil Is in the Details
Janani Rangaswami, Peter A. McCullough
PDF
Restricted access
ReplyEfficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details
Nisha A. Gilotra, Stuart D. Russell
PDF
Restricted access
Physicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) SyndromeThe Headache of Nonevidence-Based Medicine for Ischemic Heart Disease?
John G.F. Cleland
PDF
Restricted access
Low-Dose Aspirin in Heart Failure Not Complicated by Atrial FibrillationA Nationwide Propensity-Matched Study
Christian Madelaire, Gunnar Gislason, et al
Abstract

PDF

CME/MOC
Restricted access
Yet Another (Important) Goal for Heart Failure Patients
Marc A. Silver
PDF
Restricted access
Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure
Rasmus Rørth, Emil L. Fosbøl, et al
Abstract

PDF
Restricted access
FlosequinanMorbidity and Mortality
Larry A. Weinrauch
PDF
Restricted access
Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA ApprovalThe Need to Close the Gap
Antonio L. Perez, Veraprapas Kittipibul, et al
PDF
Restricted access
Observational Versus RandomizedSliding Toward Nonevidence-Based Medicine
Dipak Kotecha, Douglas G. Altman, et al
PDF
Restricted access
Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure
Michael S. Kiernan, Douglas Gregory, et al
Abstract

PDF

Pages

Advertisement